-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Trevi Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2018 to Q2 2024.
- Trevi Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $1K, a 99.3% decline year-over-year.
- Trevi Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $9K, a 99.1% decline year-over-year.
- Trevi Therapeutics, Inc. annual Interest Expense for 2023 was $391K, a 66.4% decline from 2022.
- Trevi Therapeutics, Inc. annual Interest Expense for 2022 was $1.16M, a 3.25% decline from 2021.
- Trevi Therapeutics, Inc. annual Interest Expense for 2021 was $1.2M, a 164% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)